Never Exported Vaccines At Cost Of Indians: Serum Institute Of India Chief Adar Poonawalla
Serum Institute Suffered Financial Loss Of Over Rs 1,000 Cr Due To Fire: Adar Poonawalla
Indias Drug Controller Clears Indigenous COVID Vaccines, Refuses To Take Questions On Transparency, Efficacy
Oxford COVID Vaccine Trial Volunteer Developed Neurological Symptoms: AstraZeneca CEO
Hope To Launch Oxford Vaccine In India By November: Serum Institute Chief
Oxford Vaccine Shows Promising Results, Trials In India To Begin Soon